Ananda Ghosh
Analyst, HC Wainwright and Company
Replay available
Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2025 Earnings Call
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Josh Cohen
Co-CEO
Michael DeFior
Analyst, Everycore IFI
Jim Freites
Chief Financial Officer
Justin Klee
Co-CEO
Dr. Camille Bedrosian
Chief Medical Officer
Lindsey Allen
Vice President, Investor Relations and Communications
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amylyx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.878 Good morning. My name is Lynn, and I will be your conference operator today. 00:00:05.878 -- 00:00:11.144 At this time, I would like to welcome everyone to the Amelix Pharmaceuticals First 00:00:11.144 -- 00:00:16.491 Quarter Earnings Conference Call. All participants will be in listen-only 00:00:16.491 -- 00:00:19.814 mode. After today's presentation, 00:00:19.814 -- 00:00:23.078 there will be an opportunity to ask questions. 00:00:23.078 -- 00:00:28.735 To ask a question, please press star 1 on your telephone keypad. 00:00:28.735 -- 00:00:32.800 To withdraw your question, please press star two. 00:00:32.800 -- 00:00:37.086 Please limit your questions to one with one follow-up. 00:00:37.086 -- 00:00:41.452 If you have additional questions, you may rejoin the queue. 00:00:41.452 -- 00:00:46.678 Please be advised that this call is being recorded at the company's request. 00:00:46.678 -- 00:00:52.266 I would now like to turn the call over to Lindsey Allen, Vice President, Investor 00:00:52.266 -- 00:00:54.649 Relations and Communications. 00:00:54.649 -- 00:00:56.969 Please proceed. 00:00:57.423 -- 00:01:02.353 Good morning, and thank you all for joining us today to discuss our first quarter 2025 00:01:02.353 -- 00:01:07.423 financial results and business updates. With me on the call today are 00:01:07.423 -- 00:01:11.331 Josh Cohen and Justin Klee, our co-CEOs, 00:01:11.331 -- 00:01:16.802 Dr. Camille Bedrosian, our Chief Medical Officer, and Jim Freites, our Chief Financial 00:01:16.802 -- 00:01:21.879 Officer. Before we begin, I would like to remind everyone that any statements we make 00:01:21.879 -- 00:01:26.926 or information presented on this call that are not historical facts are forward-looking 00:01:26.926 -- 00:01:32.233 s...